All

Summary:Researchers have identified new candidate genes that may be responsible for congenital deafness, offering promising targets for future diagnosis and treatment. Key Takeaways: New candidate genes linked to congenital hearing loss were identified by focusing on those regulated by the Six1 protein in developing ear cells. A significant number of these genes are expressed in both chick and human ear progenitor cells and are located in known deafness-associated chromosome regions. Conservation across species of the DNA regions regulating these genes suggests their fundamental role in ear development and hearing. New candidate genes which could be responsible for deafness have been identified. Congenital deafness (hearing loss from birth) is common, impacting around one in 1,000 babies born in the UK. The condition affects communication, social and cognitive development of children, and general quality of life. It is largely caused by mutations in genes, but many of these genes remain to be discovered. Understanding the exact mutations that cause deafness could hold the key to devising treatments. Professor Andrea Streit, expert in developmental neurobiology at King's College London, says, “Human genetics approaches have identified hundreds of ‘deafness loci’ – regions on chromosomes associated with deafness. These regions contain many genes, and the challenge is to identify the gene that causes deafness when mutated.” A new study, led by King’s College London in collaboration with George Washington University in the United States, discovered new candidates for these so-called “deafness genes.” With previous research identifying mutations in a protein, Six1, causing hearing loss, the team focused their investigation on the genes regulated by this protein. The researchers used computer-based methods to predict more than 150 potential Six1 targets in ear progenitor cells (cells which eventually form the entire inner ear) from chick embryos. Selecting four of those targets for further investigation, they revealed that Six1 binds to the DNA regions that regulate their expression and that reducing levels of Six1 stopped these genes from being activated. The team then showed that the vast majority of the genes found in chick are also expressed in human ear progenitors, and that a quarter of them fall into the chromosome regions associated with deafness. “It was very exciting to find that some of the genes regulated by Six1 are located in regions deafness locis,” says Streit. “This makes them priority candidates for being causative genes of congenital hearing loss.” https://hearingreview.com/inside-hearing/research/gene-editing-restored-hearing-in-adult-mice-with-inherited-deafness The scientists also discovered that some of the DNA regions that control Six1 target gene expression are conserved in birds and humans. This finding suggests that despite 600 million years of evolution, Six1 and its molecular mechanisms are similar in both birds and humans. They may therefore control fundamental biological processes in ear development. “It is unusual that regulatory sections of DNA, like the ones we studied, are highly conserved across species,” Streit adds. “The fact that we find them to be very similar from birds to humans indicates their critical role.” The team believe further research into Six1 and the genes it regulates could provide insight into the molecular mechanisms that control how the ear normally develops. You can read the study in the journal Development. Featured image: ID 262891282 © Voyageviewmedia | Dreamstime.com

Tag: congenital deafness

All

Study Reveals Candidate Deafness Genes

More Newborn Screening for Congenital CMV Needed

Regeneron’s Gene Therapy Improves Auditory Responses in Children with Genetic Hearing Loss

Research Finds Genes Linked to Perrault Syndrome

Sensorion, Sonova Sign Research Collaboration

Sensorion Announces Gene Therapy Collaboration

Newborn Hearing Aid Use Challenging, Researchers Find

All

Decibel Therapeutics Receives $82.2 Million Series D Financing for Advancement of Hearing Therapies

‘Common Inherited Genetic Variant’ Identified as Frequent Cause of Adult Deafness

Cochlear Announces FDA Approval for Cochlear Implantation at 9 Months

Martha’s Vineyard Revisits Sign Language History

Sensorion Awarded $11 Million Research Grant for Congenital Deafness

Sensorion Awarded $11 Million Research Grant for Congenital Deafness

Sensorion Partners with Institut Pasteur on Research Framework Targeting Hearing Loss

All

Researchers Identify Brain Factors Linked to Success of Cochlear Implants

Sorry, No Posts Found

The Hearing Review

Our Parent Company

Key Resources

Helpful Links